Carazolol-d7 (hydrochloride)
Carazolol-d7 (hydrochloride) is the deuterium labeled Carazolol hydrochloride. Carazolol hydrochloride is a highly potent antagonist of β1/β2 adrenoceptor. Carazolol hydrochloride is also a potent, selective β3-adrenoceptor agonist. Carazolol hydrochloride can be used in the research of hypertension[1].
Product Specifications
CAS Number
1276197-44-4
UNSPSC
12352005
Target
Adrenergic Receptor; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
GPCR/G Protein; Neuronal Signaling; Others
Field of Research
Cardiovascular Disease
Solubility
10 mM in DMSO
Smiles
[2H]C([2H])([2H])C(C([2H])([2H])[2H])([2H])NCC(O)COC1=C2C3=CC=CC=C3NC2=CC=C1.Cl
Molecular Formula
C18H16D7ClN2O2
Molecular Weight
341.88
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Von Willebrand Factor (3E2D10), CF555 conjugate, 0.1mg/mL
Human IgG Immunoglobulin (IG266), CF568 conjugate, 0.1mg/mL
Human IgG Immunoglobulin (IG266), CF405S conjugate, 0.1mg/mL
Fibronectin (TV-1), CF594 conjugate, 0.1mg/mL
CD79a (IGA/515), CF405S conjugate, 0.1mg/mL
